Zhu Jicai, Liu Kai, He Shan, Yang Zihao, Song Jiaying, Ju Yan, Xiong Caiyun, Zhang Guomei, Yang Wen, Tang Chunhui
Department of Pediatrics, The First People's Hospital of Yunnan Province, Medical School & Affiliated Hospital, Kunming University of Science and Technology, Kunming, Yunnan, China.
Medical School & Affiliated Hospital, Kunming University of Science and Technology. Department of Radiology, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
Intractable Rare Dis Res. 2023 Feb;12(1):58-61. doi: 10.5582/irdr.2022.01099.
The Wnt signaling pathway is vital in encouraging bone growth. gene mutations have been identified as the major cause of type XV osteogenesis imperfecta (OI). Described here is a case of complex heterozygous c.620G>A (p.R207H) and c.677C >T (p.S226L) OI caused by a novel mutation at locus c.620G >A (p.R207H). The female patient had type XV OI, distinguished by poor bone density, frequent fractures, a small stature, skull softening, lack of dentine hypoplasia, a brain malformation, and obvious blue sclera. A CT scan of the temporal bone revealed abnormalities of the inner ear, necessitating a hearing aid 8 months after birth. There was no family history of such disorders in the proband's parents. The proband inherited complex heterozygous gene variants c.677C>T (p.S226L) and c.620G>A (p.R207H) from her father and mother, respectively. Presented here is a case of OI with inner ear deformation caused by c.620G>A (p.R207H), which is a novel site mutation. This case broadens the genetic spectrum of OI and it provides a rationale for genetic testing of mothers and a medical consultation to estimate the risk of fetal illness.
Wnt信号通路在促进骨骼生长方面至关重要。基因突变已被确定为XV型成骨不全症(OI)的主要病因。本文描述了一例由位于c.620G>A(p.R207H)位点的新突变导致的复杂杂合性c.620G>A(p.R207H)和c.677C>T(p.S226L)OI病例。该女性患者患有XV型OI,其特征为骨密度低、频繁骨折、身材矮小、颅骨软化、无牙本质发育不全、脑畸形以及明显的蓝色巩膜。颞骨CT扫描显示内耳异常,出生后8个月需要佩戴助听器。先证者的父母均无此类疾病的家族史。先证者分别从其父亲和母亲那里遗传了复杂杂合性基因变异c.677C>T(p.S226L)和c.620G>A(p.R207H)。本文呈现了一例由c.620G>A(p.R207H)这一新型位点突变导致内耳畸形的OI病例。该病例拓宽了OI的遗传谱,为母亲进行基因检测及医疗咨询以评估胎儿患病风险提供了依据。